Scienmag

SEPTEMBER 9, 2020

Credit: © 2020 KAUST Purifying specific protein molecules from complex mixtures will become easier with a simpler way to detect a molecular “tag” commonly used as a handle to grab the proteins.

Protein 60

Protein Genetics 60

Rethinking Clinical Trials

DECEMBER 20, 2023

Further efforts are urgently needed to increase diversity in the cardiology workforce, which will improve clinical trial diversity and cardiovascular health for all. Approaches from the whole scientific community to tackle the inequality in workforce, trial leadership and trial participants have to be developed.

Clinical Trials 169

Clinical Trials Clinical Trials Trials Cardiology 169

Rethinking Clinical Trials

JANUARY 31, 2024

DIHI approaches this work through four pillars of innovation: implementation and health delivery science, health technology innovation, leadership and workforce development, and best practices development and dissemination. . – How do you get reliable information and data for care that is received outside of Duke?

Production 161

Production Development Clinical Trials Clinical Trials 161

Rethinking Clinical Trials

FEBRUARY 28, 2024

We need to train the workforce for what we need them to do. I hope we see further development of education programs that support the workforce with the skills needed. I hope we see further development of education programs that support the workforce with the skills needed.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

Rethinking Clinical Trials

AUGUST 23, 2022

For the theme of improving representation and diversity among clinical investigators, having a more representative clinical trial workforce might translate to more diverse participants. We have seen that having a higher proportion of women authors resulted in a higher proportion of women enrolled per trial. Learn more. pctGR, @Collaboratory1.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Medicine 130

XTalks

MAY 2, 2024

Several common themes included the integration of technology like blockchain and AI in food safety, the importance of a well-trained workforce and the continuous need for industry collaboration. During the event, Xtalks interviewed several sponsors as well as the event’s Chair, Glenford Jameson.

Compliance 110

Compliance Regulation Production Containment 110

pharmaphorum

JUNE 12, 2022

Beti-cel has already been approved for marketing in Europe as Zynteglo, with a price tag of around $1.8 million price tag, saying its ability to help patients reach sustained transfusion independence justified its high price. Beti-cel offers another potentially curative treatment for a much broader range of patients.

Gene Therapy 59

Gene Therapy Gene Marketing Trials 59